Sonographic 3D Measurement of Fetal Thymus May be Used to Predict the Small Baby in Pregnancy.

Intrauterine Growth Restriction Clinical Trial

— IUGR  

Official title:

Prenatal Sonographic 3D VOCAL Thymic Volume Calculation May Predict Intrauterine Growth Restriction

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05328453
• Other study ID #: 2016/181
• Status: Completed
• Start date: March 1, 2016
• Est. completion date: March 1, 2017

Study information

• Verified date: April 2022
• Source: Karadeniz Technical University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The exact etiology of intrauterine growth restriction (IUGR) remains unclear but is known to involve immunologic/infectious factors. The thymus is one of the main organs involved in the development of the fetal immune system. The aim of this study was to explore the association between 3D fetal thymus volume (VOCAL) on ultrasound and intrauterine growth restiction by adding the 3-dimensional measurement of thymus volume to the routine fetal ultrasound scan at 15-24 week of gestation.

Investigators performed a prospective clinical study in 100 pregnant women in their second trimester of pregnancy who attended the Fetal Medicine Unit of the Medicine Faculty of Karadeniz Technical University during the study period. Maternal age, gravida, para, BMI, blood pressure, gestational age, BPD, FL ,AC, EFW and fetal timus volume measured with VOCAL programme are recorded. For all patients routine clinical and ultrasound examinations were performed during pregnancy. Gestational age at birth, way of birth and newborn birthweight were recorded. The results were statistically compared in the SPSS 13.0 program. Student-t test and chi-square test were used for statistical analysis. ROC curve analysis was used for limit values. The data of patients with IUGR and without IUGR were compared. The ability of the thymus volume to predict the IUGR was tested using binary logistic regression analysis. P value <0.05 was considered statistically significant.

Description:

A signed informed consent form for voluntary participation in the study was provided by all the women. A record was made for each patient of age, gravida, parity, body mass index (BMI), and sonographic measurements of biparietal diameter (BPD), abdominal circumference (AC), femur length (FL), and estimated fetal weight (EFW).

3D Fetal thymus volume (TV) was measured by using a VOLUSON E-10 ultrasonography device, by a single researcher experienced in the use of obstetric ultrasound with a transabdominal volumetric probe. The fetal thymus, transverse section of the fetal chest, and the 3 vessel sections were visualised, then the 3D US modality was activated and the thymus volume was obtained immediately with the same probe.

All cases were followed up in terms of pregnancy complications (IUGR development) until delivery.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: March 1, 2017
• Est. primary completion date: March 1, 2017
• Gender: Female
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Aged 18-35 years,

• Who presented at the polyclinic for routine antenatal follow-up at 15-24 weeks

• Had no complaints.

• Had normal renal, hepatic, and thyroid functions test results.

Exclusion Criteria:

• Any known endocrinopathy,

• systemic disease,

• collagen disorder,

• hypercholesterolemia,

• hemoglobinopathy

• history of neoplasm,

• current or previous cardiovascular disease,

• the use of any drugs within the 3 months before the pregnancy,

• multiple pregnancy,

• current smoking,

• abnormal renal, hepatic, or thyroid function test results,

• the presence of any findings of fetal chromasomal or structural anomaly,

• refusal to participate in the study.

Related Conditions & MeSH terms

• Fetal Growth Retardation
• Intrauterine Growth Restriction

Intervention

Diagnostic Test:
• Fetal prenatal ultrasonographic evaluation.
Routine fetal ultrasonography at 15-24 weeks. All sonographic measurements including 3D fetal thymus calculation was measured.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Karadeniz Technical University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	IUGR development.	IUGR was accepted as EFW below the 10th percentile according to BPD, FL, and AC	One year period.